---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-155448"
form_type: "8-K"
ticker: "SLNO"
cik: "0001484565"
company_name: "SOLENO THERAPEUTICS INC"
filed_at: "2023-05-26T23:59:59+00:00"
generated_at: "2026-06-14T12:50:02.905549+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Soleno Therapeutics stockholders approve all six proposals at 2023 annual meeting

## Summary
- Elected Ernest Mario and Birgitte Volck as Class II directors with ~64.8% and ~66.7% of votes cast, respectively.
- Ratified Marcum LLP as independent auditor for fiscal 2023 (5,977,682 for, 113,718 against).
- Advisory say-on-pay approved (4,019,358 for, 111,424 against); board accepted three-year frequency.
- Approved amended 2014 Equity Incentive Plan (3,874,198 for, 254,424 against).
- Approved issuance of shares upon exercise of warrants from May 8, 2023 private placement (4,003,720 for, 132,021 against).

## SEC filing metadata
- accession: 0001193125-23-155448
- form_type: 8-K
- ticker: SLNO
- cik: 0001484565
- company_name: SOLENO THERAPEUTICS INC
- filed_at: 2023-05-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1484565/000119312523155448/0001193125-23-155448-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1484565/000119312523155448/d515984d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-155448
- JSON: https://secwatch.observer/filing/0001193125-23-155448.json
- Plain text: https://secwatch.observer/filing/0001193125-23-155448.txt

## Key facts
- Shareholder Votes
  SOLENO THERAPEUTICS INC shareholders approved Approval of Named Executive Officer compensation on an advisory basis at the 2023-05-25 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2023-05-25
  source text: Votes For Votes Against Abstentions Broker Non-Votes 4,019,358 111,424 15,486 1,949,693
  evidence_url: https://www.sec.gov/Archives/edgar/data/1484565/000119312523155448/0001193125-23-155448-index.htm
- Shareholder Votes
  SOLENO THERAPEUTICS INC shareholders approved Ratification of appointment of Marcum LLP as independent registered public accounting firm for fiscal year ending December 31, 2023 at the 2023-05-25 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-05-25
  source text: Votes For Votes Against Abstentions Broker Non-Votes 5,977,682 113,718 4,561 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1484565/000119312523155448/0001193125-23-155448-index.htm
- Shareholder Votes
  SOLENO THERAPEUTICS INC shareholders approved Approval of frequency of stockholder votes on Named Executive Officer compensation on an advisory basis at the 2023-05-25 meeting.
  - Proposal: say on pay frequency
  - Outcome: passed
  - Meeting: 2023-05-25
  source text: Votes For Every 3 Years Votes for Every 2 Years Votes for Every 1 Years Abstentions Broker Non-Votes 2,234,536 18,934 1,865,518 27,280 1,949,693
  evidence_url: https://www.sec.gov/Archives/edgar/data/1484565/000119312523155448/0001193125-23-155448-index.htm
- Shareholder Votes
  SOLENO THERAPEUTICS INC shareholders approved Approval of issuance of shares upon exercise of warrants sold in private placement on May 8, 2023 at the 2023-05-25 meeting.
  - Outcome: passed
  - Meeting: 2023-05-25
  source text: Votes For Votes Against Abstentions Broker Non-Votes 4,003,720 132,021 10,527 1,949,693
  evidence_url: https://www.sec.gov/Archives/edgar/data/1484565/000119312523155448/0001193125-23-155448-index.htm
- Shareholder Votes
  SOLENO THERAPEUTICS INC shareholders approved Approval of Amended and Restated 2014 Equity Incentive Plan at the 2023-05-25 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2023-05-25
  source text: Votes For Votes Against Abstentions Broker Non-Votes 3,874,198 254,424 17,646 1,949,693
  evidence_url: https://www.sec.gov/Archives/edgar/data/1484565/000119312523155448/0001193125-23-155448-index.htm
- Shareholder Votes
  SOLENO THERAPEUTICS INC shareholders approved Election of two Class II directors at the 2023-05-25 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-05-25
  source text: Nominee Votes For Votes Withheld Percent of Voted Broker Non-Votes Ernest Mario 3,950,528 195,740 64.8 % 1,949,693 Birgitte Volck 4,066,365 79,903 66.7 % 1,949,693
  evidence_url: https://www.sec.gov/Archives/edgar/data/1484565/000119312523155448/0001193125-23-155448-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.